J Handel
Papers
1
Total Citations
30
H-Index
1
About
Dr. J. Handel is a leading figure in urologic oncology, with a focused expertise in the comparative effectiveness and cost analysis of treatments for small renal masses. His research directly addresses the critical question of value in cancer care, particularly for T1a renal tumors. His most influential work, a 2015 study comparing percutaneous cryoablation to partial nephrectomy, provides a rigorous, hospital-perspective cost analysis. By retrospectively examining data from 37 cryoablations, 26 open, and 102 robot-assisted partial nephrectomies, Dr. Handel demonstrated that percutaneous cryoablation offers a significant economic advantage without compromising oncologic principles. This landmark paper, cited 30 times, has shaped clinical decision-making and resource allocation in urology. Dr. Handel’s contributions are essential for students and researchers interested in the intersection of surgical innovation, health economics, and patient-centered outcomes, establishing him as a key voice in optimizing treatment pathways for renal cell carcinoma.
Research Focus
Key Achievements
Top Papers
- 1